CASP3 and infection: Following lethal LVS infection, 25% of mice treated with Nec-1 survived (Fig 7A) and necrotic lung damage was also reduced (Fig 7B), while wildtype control mice and those treated with a caspase-3 inhibitor were not protected and had comparable pathology.